Neoplasms: all 9,616 studies
Page 80 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF MutationsCompletedNCT01531361Phase 1
- Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling TransplantationCompletedNCT01530581Phase 3
- Temsirolimus in Combination With Metformin in Patients With Advanced CancersTerminatedNCT01529593Phase 1
- First in Human Trial of TAS266 in Patients With Advanced Solid TumorsTerminatedNCT01529307Phase 1
- Metformin in Children With Relapsed or Refractory Solid TumorsCompletedNCT01528046Phase 1
- Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal ImpairmentCompletedNCT01527929Phase 1
- A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced CancerStatus unknownNCT01527331Not applicable
- Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic NeoplasmTerminatedNCT01525706Phase 1
- Radiofrequency Ablation for the Treatment of Gastric DysplasiaCompletedNCT01523912Phase 4
- Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological PatientsCompletedNCT01523652
- PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor MalignanciesStatus unknownNCT01522989Phase 1
- A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid TumorsWithdrawnNCT01521299Phase 1
- Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative NeoplasmsCompletedNCT01520220Phase 1
- Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid TumorsCompletedNCT01518413Phase 1
- BiPAP-Vapotherm RCTWithdrawnNCT01518140Phase 2
- A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid TumorsCompletedNCT01517464Phase 1
- Phase 1 Study of KHK2898 in Subjects With Advanced Solid TumorsTerminatedNCT01516645Phase 1
- Confocal Endomicroscopy for GI Neoplasia StudyCompletedNCT01515514
- Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct ObstructionCompletedNCT01514214Not applicable
- Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary StentCompletedNCT01512563Not applicable
- A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid TumorsTerminatedNCT01506934Phase 1
- Cognitive Assessments in Patients With Cancer Undergoing ChemotherapyCompletedNCT01506440
- Auto Transplant for High Risk or Relapsed Solid or CNS TumorsCompletedNCT01505569Not applicable
- Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic CancerCompletedNCT01505153Phase 1
- Clinical Trial of ARQ 761 in Advanced Solid TumorsCompletedNCT01502800Phase 1
- Family Genetics Health Education and Healthy BehaviorsCompletedNCT01498276
- Photoacoustic Endoscopy in Endometrial CancerWithdrawnNCT01498237Early Phase 1
- Lapatinib and Bortezomib in Patients With Advanced MalignanciesTerminatedNCT01497626Phase 1
- A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment RegimenCompletedNCT01497470Phase 1
- A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid TumorsCompletedNCT01494688Phase 1
- Assessment of in Vivo Skeletal Muscle Viscoelasticity (ARFI Imaging) With Aging and CancerCompletedNCT01484821Not applicable
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaCompletedNCT01484015Phase 1
- Prediction of Intraoperative Blood Loss and Postoperative Recovery by Liver Stiffness Measurement (Fibroscan®) in Right HepatectomyCompletedNCT01483859Not applicable
- Risk Factors for Residual Neoplasia After Endoscopic Mucosal ResectionCompletedNCT01478919
- A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
- A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast CancersStatus unknownNCT01478438Not applicable
- Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic MassWithdrawnNCT01477788
- A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic MalignanciesTerminatedNCT01476657Phase 1
- Second Malignant Neoplasms After Childhood ALL TherapyCompletedNCT01476462
- Adolescent Loss: The Impact of Loss on Adolescent Oncology PatientsCompletedNCT01473862
- Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant LymphomaCompletedNCT01473095Phase 1
- ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerCompletedNCT01472146Phase 2
- Study of ABT-700 in Subjects With Advanced Solid TumorsCompletedNCT01472016Phase 1
- An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor TypesCompletedNCT01472003Phase 1
- Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal NeoplasiaCompletedNCT01471756Phase 4
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesCompletedNCT01471067Phase 1
- A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid TumorsCompletedNCT01469130Phase 1
- Extracolonic Findings on Computed Tomography (CT) ColonographyStatus unknownNCT01465425
- MRI for Assessment of Hypoxia-Induced Prostate Cancer AggressivenessActive, not recruitingNCT01464216
- Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian CancerCompletedNCT01462890Phase 3
- The Role of the EKG in Anticancer Drug DevelopmentCompletedNCT01462383
- A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except LeukemiaCompletedNCT01462175Phase 1
- Surgical Complications Related to Primary or Interval Debulking in Ovarian NeoplasmCompletedNCT01461850Phase 3
- Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial CarcinomaCompletedNCT01460979Phase 2
- Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic TransplantationCompletedNCT01460420Phase 1/2
- A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersCompletedNCT01460134Phase 1
- Stenting Malignant Jaundice for Quality of LifeCompletedNCT01459965Not applicable
- Cancer Genome AnalysisStatus unknownNCT01458704
- Computertomography-guided Wire Marking of the LiverCompletedNCT01457599
- Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic CancerTerminatedNCT01457131Phase 1
- Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid TumorsCompletedNCT01455584Phase 1
- A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid TumorsCompletedNCT01455532Phase 1
- A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder CancerCompletedNCT01454089Phase 2
- Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid TumorWithdrawnNCT01453465
- Endobronchial Valves in Persistent Air LeakCompletedNCT01451359Not applicable
- A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid TumorsCompletedNCT01449058Phase 1
- Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic CancerCompletedNCT01446458Phase 1
- More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided SurgeryWithdrawnNCT01445691Phase 2
- A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple MyelomaWithdrawnNCT01445587Phase 2
- Dasatinib in Combination With Bevacizumab to Treat Advanced Solid TumorsCompletedNCT01445509Phase 1
- Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain MetastasesCompletedNCT01445483
- A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid TumorsCompletedNCT01445106Phase 1
- A Study of AMG 820 in Subjects With Advanced Solid TumorsCompletedNCT01444404Phase 1
- Family and Coping Oriented Palliative Homecare Nursing Aimed at Advanced Cancer PatientsCompletedNCT01444157Phase 3
- MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal AdenocarcinomaCompletedNCT01443065Phase 2
- Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal CancerCompletedNCT01440270Phase 2
- Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.CompletedNCT01439152Phase 1
- GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced CancersWithdrawnNCT01437280Phase 1
- A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor CancersCompletedNCT01436565Phase 1
- Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)Status unknownNCT01435720Phase 1/2
- Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid MalignanciesCompletedNCT01435447Phase 2
- BN80927 in Patients With Advanced Malignant Solid TumorsCompletedNCT01435096Phase 1
- Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal CancerCompletedNCT01434394Phase 2/3
- DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or SiblingsCompletedNCT01434355
- Biomarkers to Distinguish Benign From Malignant Thyroid NeoplasmCompletedNCT01433809
- Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor ProgressionCompletedNCT01433224
- Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital StaffCompletedNCT01432431Not applicable
- Physical Activity Advices to Prevent Loss of Autonomy in Cancer Treated Elderly Patients. An Intervention Randomized StudyCompletedNCT01432067Not applicable
- Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)CompletedNCT01431547Phase 1
- VITamine D Supplementation in RenAL Transplant Recipients - VITALECompletedNCT01431430Phase 4
- Femoral Bone MetastasesActive, not recruitingNCT01428895Not applicable
- A Phase I Study of E7050 in Subjects With Solid TumorsCompletedNCT01428141Phase 1
- The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast ReconstructionStatus unknownNCT01427400Phase 4
- Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced CancerCompletedNCT01423903Phase 1
- The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver MetastasesCompletedNCT01423734
- Acupuncture for the Immune System in Radiation Cancer PatientsWithdrawnNCT01422928Phase 3
- Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid MalignanciesCompletedNCT01421173Phase 1
- Ovarian Reserve Testing in Female Young Adult Cancer SurvivorsActive, not recruitingNCT01421095Not applicable
- Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid TumorsCompletedNCT01421004Phase 1
- Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)CompletedNCT01420874Phase 1